Dexrazoxane-a promising antidote in the treatment of accidental extravasation of anthracyclines

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Dexrazoxane-a promising antidote in the treatment of accidental extravasation of anthracyclines. / Jensen, Jesper Naested; Lock-Andersen, Jørgen; Langer, Seppo W; Mejer, Johannes.

I: Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery, Bind 37, Nr. 3, 2003, s. 174-5.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Jensen, JN, Lock-Andersen, J, Langer, SW & Mejer, J 2003, 'Dexrazoxane-a promising antidote in the treatment of accidental extravasation of anthracyclines', Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery, bind 37, nr. 3, s. 174-5. https://doi.org/10.1080/02844310310007791

APA

Jensen, J. N., Lock-Andersen, J., Langer, S. W., & Mejer, J. (2003). Dexrazoxane-a promising antidote in the treatment of accidental extravasation of anthracyclines. Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery, 37(3), 174-5. https://doi.org/10.1080/02844310310007791

Vancouver

Jensen JN, Lock-Andersen J, Langer SW, Mejer J. Dexrazoxane-a promising antidote in the treatment of accidental extravasation of anthracyclines. Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery. 2003;37(3):174-5. https://doi.org/10.1080/02844310310007791

Author

Jensen, Jesper Naested ; Lock-Andersen, Jørgen ; Langer, Seppo W ; Mejer, Johannes. / Dexrazoxane-a promising antidote in the treatment of accidental extravasation of anthracyclines. I: Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery. 2003 ; Bind 37, Nr. 3. s. 174-5.

Bibtex

@article{d00f1b4052fe4b9080bd2fd454bad211,
title = "Dexrazoxane-a promising antidote in the treatment of accidental extravasation of anthracyclines",
abstract = "Accidental extravasation of chemotherapy containing anthracycline often causes mutilating complications as a result of extensive tissue necrosis. Treatment therefore consists of extensive surgical debridement. We present the case of a 41-year-old woman with breast cancer who experienced extravasation of epirubicin. She was treated with an intravenous infusion of dexrazoxane for three successive days and recovered without surgical treatment and only slightly dysaesthesia in the surrounding tissue. Although infusion of dexrazoxane for this indication is still experimental we consider it a promising treatment for patients who have accidental extravasation of anthracyclines.",
keywords = "Adult, Antibiotics, Antineoplastic/administration & dosage, Antineoplastic Agents/therapeutic use, Breast Neoplasms/drug therapy, Epirubicin/administration & dosage, Extravasation of Diagnostic and Therapeutic Materials/drug therapy, Female, Humans, Razoxane/therapeutic use",
author = "Jensen, {Jesper Naested} and J{\o}rgen Lock-Andersen and Langer, {Seppo W} and Johannes Mejer",
year = "2003",
doi = "10.1080/02844310310007791",
language = "English",
volume = "37",
pages = "174--5",
journal = "Journal of Plastic Surgery and Hand Surgery",
issn = "2000-656X",
publisher = "Taylor & Francis",
number = "3",

}

RIS

TY - JOUR

T1 - Dexrazoxane-a promising antidote in the treatment of accidental extravasation of anthracyclines

AU - Jensen, Jesper Naested

AU - Lock-Andersen, Jørgen

AU - Langer, Seppo W

AU - Mejer, Johannes

PY - 2003

Y1 - 2003

N2 - Accidental extravasation of chemotherapy containing anthracycline often causes mutilating complications as a result of extensive tissue necrosis. Treatment therefore consists of extensive surgical debridement. We present the case of a 41-year-old woman with breast cancer who experienced extravasation of epirubicin. She was treated with an intravenous infusion of dexrazoxane for three successive days and recovered without surgical treatment and only slightly dysaesthesia in the surrounding tissue. Although infusion of dexrazoxane for this indication is still experimental we consider it a promising treatment for patients who have accidental extravasation of anthracyclines.

AB - Accidental extravasation of chemotherapy containing anthracycline often causes mutilating complications as a result of extensive tissue necrosis. Treatment therefore consists of extensive surgical debridement. We present the case of a 41-year-old woman with breast cancer who experienced extravasation of epirubicin. She was treated with an intravenous infusion of dexrazoxane for three successive days and recovered without surgical treatment and only slightly dysaesthesia in the surrounding tissue. Although infusion of dexrazoxane for this indication is still experimental we consider it a promising treatment for patients who have accidental extravasation of anthracyclines.

KW - Adult

KW - Antibiotics, Antineoplastic/administration & dosage

KW - Antineoplastic Agents/therapeutic use

KW - Breast Neoplasms/drug therapy

KW - Epirubicin/administration & dosage

KW - Extravasation of Diagnostic and Therapeutic Materials/drug therapy

KW - Female

KW - Humans

KW - Razoxane/therapeutic use

U2 - 10.1080/02844310310007791

DO - 10.1080/02844310310007791

M3 - Journal article

C2 - 12841619

VL - 37

SP - 174

EP - 175

JO - Journal of Plastic Surgery and Hand Surgery

JF - Journal of Plastic Surgery and Hand Surgery

SN - 2000-656X

IS - 3

ER -

ID: 247891831